Article Details
Retrieved on: 2022-12-28 00:35:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
SHANGHAI, Dec. 27, 2022 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”), a biopharmaceutical company focused on the development, ...
Article found on: b2bchief.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here